Guy Villax is CEO of Hovione.
Guest Viewpoint: A Case for an FDA Dean's List
Quality is a matter of culture more than metrics. In this opinion article, the author presents arguments for an FDA Dean's List as a means to nurture a quality culture within the industry.
A Case for an FDA Dean's List
FDA is moving in the right direction in terms of implementing stratification by levels of compliance across pharmaceutical manufacturing sites. However, quality is a matter of culture more than metrics. In this opinion article, the author presents arguments for an FDA Dean's List as a means to nurture a quality culture within the industry.
Pharmaceutical Manufacturing and Supply-Chain Trends to 2020
A breach in the pharmaceutical supply chain is only the tip of the iceberg.